SCHEMBL5028409

SCHEMBL5028409

C=Cc1[nH]c(NC2CCC(CNCCN3C(=O)CCC(CC(=O)O)=C4CC=CC=C43)CC2)nc1C=CC

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 3/20 0.32
ITGAV P06756 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5028408 1.00 ITGB3 (0.32) ITGB3ITGAV
SCHEMBL5028375 0.67 ITGB3 (0.46) ITGB3ITGAV
SCHEMBL5030065 0.66
SCHEMBL5023988 0.64 ITGB3 (0.47) ITGB3ITGAV
SCHEMBL5025709 0.56 ITGB3 (0.42) ITGB3ITGAV
SCHEMBL23772862 0.50 NPC1 (0.30)
SCHEMBL5025565 0.47 GAA (0.36)
SCHEMBL23353741 0.45 NPSR1 (0.31)
SCHEMBL1108308 0.45 MEN1 (0.44)
SCHEMBL28131810 0.45 LMNA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221082-A1 Ligands of Integrin Receptors ABBOTT GMBH & CO. KG (DE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221082-A1 Ligands of Integrin Receptors ITGB3, ITGAV, ITGA2B ITGB3 1/4885ITGAV 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.